MyFinsight
Home
Blog
About
Contact
Issuance of common stock
related to...
$4,334,670
Net cash provided by
financing activities
$4,334,670
Net decrease in cash
and cash...
-$3,653,623
Canceled cashflow
$4,334,670
Accounts payable,
accrued expenses and...
$639,080
Depreciation and
amortization
$255,445
Stock-based compensation
expense
$219,114
Inventory
-$174,162
Accounts receivable
-$103,872
Loss from equity
method investment
-$13,361
Provision for credit
losses
$4,164
Prepaid expenses and
other assets
-$3,277
Net cash used in
operating activities
-$7,846,276
Canceled cashflow
$1,412,475
Net cash (used in)
provided by investing...
-$142,017
Net loss
-$9,140,038
Change in fair value of
acquisition contingencies
$75,280
Inventory obsolescence
recoveries
-$27,884
Deferred revenue
-$14,200
Non-cash lease expense
-$1,349
Purchases of property and
equipment
$142,017
Back
Back
Cash Flow
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)
source: myfinsight.com